New imaging tools to improve targeted cancer therapies
Official title: Novel Isotopic Spectroscopy Imaging Tools for Advancing Targeted Alpha Cancer Therapies
Funded at Qscint Imaging Solutions, LLC · NIH-10922240 · Data updated 2026-11-12
This study is working on new imaging tools to help doctors see how targeted cancer treatments work in the body, which could lead to better and more effective therapies for patients.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Qscint Imaging Solutions, LLC NIH-funded |
| Lab location | 1 site (Tucson, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $811,503 |
| NIH project number | 1R44EB035459-01A1 |
| Project ID | NIH-10922240 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients with specific types of cancer that are being targeted by alpha particle therapies.
✕Less likely to help
Patients with non-cancerous conditions or those whose cancer types are not targeted by this therapy may not benefit from this research.
What this research studies
This research focuses on developing advanced imaging tools that enhance targeted alpha therapy for cancer treatment. By creating carrier molecules that bind specifically to cancer cells and emit alpha particles, the research aims to visualize how these therapies distribute within the body at a near-cellular level. The innovative imaging technology will help researchers understand the behavior of these therapies and their isotopes, potentially leading to more effective cancer treatments. Patients may benefit from improved targeting of cancer therapies, resulting in better treatment outcomes.
Why it matters
Potential benefit: If successful, this research could lead to more effective and precise cancer treatments with fewer side effects.
How similar studies have gone: While targeted alpha therapy is a promising approach, the development of specific imaging tools for this purpose is relatively novel and has not been extensively tested.
Where this research is happening
-
Qscint Imaging Solutions, LLC
Tucson, United States Active
Researchers
- Principal investigator: Moore, Jared William — Qscint Imaging Solutions, LLC
- Study coordinator: Moore, Jared William
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.